Loading company…
Prestige Biologics provides contract research, development, and manufacturing services for biopharmaceuticals.
Founded in 2015, Prestige Biologics is a CDMO providing research, development, testing, and production services across the biopharmaceutical lifecycle. It is a division of Prestige BioPharma Ltd. and offers a cloud-based platform for production management. The company is based in Cheongju, South Korea. In 2018, it raised KRW 25 billion in venture debt funding from Kamur Partners.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in